REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor Presentation

2 Sep 2022 10:02

RNS Number : 1044Y
Byotrol PLC
02 September 2022
 

 

 

 

Byotrol plc

("Byotrol" or the "Company")

Investor Presentation

 

Byotrol plc (AIM: BYOT), the developer of anti-microbial technologies, is pleased to announce that David Traynor, CEO, Chris Sedwell, CFO, and Vivan Pinto, CGO, will provide a live presentation relating to Final Results 2022 via the Investor Meet Company platform on 15th September 2022 at 11:00am BST.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet Byotrol plc via:

 

https://www.investormeetcompany.com/byotrol-plc/register-investor

 

Investors who already follow Byotrol on the Investor Meet Company platform will automatically be invited.

 

 

For further information, visit www.byotrolplc.com, follow on twitter @byotrol, or contact

 

Byotrol plc

David Traynor - Chief Executive Officer

Chris Sedwell - Chief Financial Officer 01925 742 000

 

finnCap Limited (Nominated Adviser and Broker)

Geoff Nash/James Thompson - Corporate Finance

Richard Chambers - ECM 020 7220 0500

 

Flagstaff Strategic and Investor Communications 020 7129 1474

Tim Thomson/Andrea Seymour/Fergus Melon byotrol@flagstaffcomms.com

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading infection prevention and control company, operating globally in the animal health, human health, facilities management, and consumer sectors.

 

Byotrol develops unique antimicrobial technologies for use on surfaces, skin and instruments, which it then commercialises through market-leading distribution partners in each sector.

 

Byotrol's antimicrobial technologies can be licensed for use in leading brands, to significantly improve their product claims, while reassuring consumers and end-users of their efficacy and quality.

 

Founded in 2005, the Company develops technologies and products with the aim of providing easier, safer and cleaner lives for everyone. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKBBQFBKKOCK
Date   Source Headline
5th Aug 20097:00 amRNSUpdate on current business
30th Jul 20094:46 pmRNSResult of AGM
9th Jul 20098:07 amRNSAnnual Report & Accounts
30th Jun 20094:37 pmRNSHolding(s) in Company
24th Jun 20099:29 amRNSDirector/PDMR Shareholding
23rd Jun 20094:57 pmRNSDirector/PDMR Shareholding
22nd Jun 20098:00 amRNSDirectorate Change
16th Jun 20097:00 amRNSFinal Results
11th May 20097:00 amRNSDirectorate Change
2nd Mar 20098:00 amRNSUpdate on Trading
28th Nov 200810:58 amRNSTotal Voting Rights
25th Nov 20081:52 pmRNSHolding(s) in Company
25th Nov 20081:51 pmRNSHolding(s) in Company
24th Nov 20081:20 pmRNSHolding(s) in Company
24th Nov 20087:00 amRNSInterim Results
20th Nov 20083:32 pmRNSHolding(s) in Company
20th Nov 200812:28 pmRNSHolding(s) in Company
19th Nov 200810:30 amRNSResult of EGM
31st Oct 20087:00 amRNSConfirmation of posting of Circular
30th Oct 20087:30 amRNSNHS Supply Chain Listing
29th Oct 200812:00 pmRNSProposed Placing / Notice of General Meeting
7th Oct 20087:00 amRNSHealthcare Update
30th Sep 200810:46 amRNSTotal Voting Rights
5th Sep 200812:00 pmRNSHolding(s) in Company
1st Sep 200811:14 amRNSDirector/PDMR Shareholding
29th Aug 20089:00 amRNSTotal Voting Rights
21st Aug 200812:37 pmRNSHolding(s) in Company Replace
20th Aug 200812:00 pmRNSHolding(s) in Company
18th Aug 20087:00 amRNSDirector/PDMR Shareholding
6th Aug 200812:18 pmRNSDirector/PDMR Shareholding
31st Jul 20083:09 pmRNSResult of AGM
18th Jul 20087:54 amRNSDirector/PDMR Shareholding
16th Jul 20087:53 amRNSDirector/PDMR Shareholding
8th Jul 20087:00 amRNSDirector/PDMR Shareholding
4th Jul 20083:00 pmRNSAnnual Report and Accounts
3rd Jul 20084:49 pmRNSHolding(s) in Company
2nd Jul 20084:00 pmRNSHolding(s) in Company
27th Jun 20088:50 amRNSHolding(s) in Company
17th Jun 20087:00 amRNSFinal Results
29th May 20081:50 pmRNSResult of Meeting
27th Feb 20087:02 amRNSLatest developments
13th Feb 20088:57 amRNSHolding(s) in Company
5th Feb 20081:19 pmRNSHolding(s) in Company
11th Jan 200812:52 pmRNSHolding(s) in Company
19th Dec 200712:22 pmRNSHolding(s) in Company
29th Nov 20077:01 amRNSInterim Results
28th Sep 200712:02 pmRNSTotal Voting Rights
25th Sep 20073:19 pmRNSHolding(s) in Company
18th Sep 20074:50 pmRNSAdditional Listing
6th Sep 20074:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.